This aligns with our previous studies showing that neuroinflammation levels, as measured with TSPO PET, provide additional predictive information on clinical and cognitive decline across the FTLD, over and above measures of brain atrophy, such as structural MRI.26,28. The gene discussed is TSPO; the disease is Mental deterioration.